Form 4 Tracker
Vir Biotechnology, Inc.
VIR

29 insider filings · Latest: Jun 9, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 24, 2026Feb 26 9:54 PMVerneuil Vanina deEVP, General Counsel, Corp Sec
Sale
3,117$9.53$29.7K126,682(D)

View →

Feb 24, 2026Feb 26 9:54 PMBacker Marianne DeDirector, Chief Executive Officer
Sale
14,762$9.53$140.7K1,020,704(D)

View →

Feb 25, 2026Feb 26 2:00 AMSVF Endurance (Cayman) Limited
Proposed Sale
400,000$9.49$3.8M

View →

Feb 25, 2026Feb 25 3:48 PMde Verneuil Vanina
Proposed Sale
13,700$9.82$134.5K

View →

Feb 25, 2026Feb 25 2:48 PMEisner Mark
Proposed Sale
1,889$9.82$18.5K

View →

Feb 23, 2026Feb 25 12:13 AMBrent SabatiniSVP, Chief Accounting Officer
Sale
1,829$7.45$13.6K71,043(D)

View →

Feb 23, 2026Feb 25 12:12 AMJason O'ByrneEVP & Chief Financial Officer
Sale
2,089$7.45$15.6K164,249(D)

View →

Feb 23, 2026Feb 25 12:11 AMMark EisnerEVP and Chief Medical Officer
Sale
2,089$7.45$15.6K157,529(D)

View →

Feb 23, 2026Feb 25 12:10 AMVerneuil Vanina deEVP, General Counsel, Corp Sec
Sale
4,445$7.45$33.1K129,799(D)

View →

Feb 23, 2026Feb 25 12:09 AMBacker Marianne DeDirector, Chief Executive Officer
Sale
19,039$7.45$141.9K1,035,466(D)

View →

Feb 24, 2026Feb 24 10:16 PMEisner Mark
Proposed Sale
1,616$9.53$15.4K

View →

Feb 24, 2026Feb 24 10:07 PMDe Backer Marianne
Proposed Sale
14,762$9.53$140.7K

View →

Feb 24, 2026Feb 24 9:57 PMO'Byrne Jason
Proposed Sale
1,634$9.53$15.6K

View →

Feb 24, 2026Feb 24 9:53 PMSabatini Brent
Proposed Sale
1,430$9.53$13.6K

View →

Feb 24, 2026Feb 24 9:42 PMde Verneuil Vanina
Proposed Sale
3,117$9.53$29.7K

View →

Feb 24, 2026Feb 24 9:33 PMVICKI LEE SATO
Proposed Sale
20,377$7.43$151.4K

View →

Feb 23, 2026Feb 23 9:52 PMO'Byrne Jason
Proposed Sale
2,089$7.45$15.6K

View →

Feb 23, 2026Feb 23 9:34 PMEisner Mark
Proposed Sale
2,089$7.45$15.6K

View →

Feb 23, 2026Feb 23 9:32 PMDe Backer Marianne
Proposed Sale
19,039$7.45$141.9K

View →

Feb 23, 2026Feb 23 9:22 PMde Verneuil Vanina
Proposed Sale
4,445$7.45$33.1K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 9, 2026Jun 10 10:21 PMTimothy CoughlinDirector
Grant/Award
32,000$8.5116,000(D)

View →

May 27, 2026May 28 11:25 PMCharles Elliott SigalDirector
Grant/Award
16,000$9.1016,000(D)

View →

May 27, 2026May 28 11:25 PMJanet NapolitanoDirector
Grant/Award
16,000$9.1016,000(D)

View →

May 27, 2026May 28 11:25 PMRobert J MoreDirector
Grant/Award
16,000$9.1016,000(D)

View →

May 27, 2026May 28 11:24 PMJeffrey S. HatfieldDirector
Grant/Award
16,000$9.1016,000(D)

View →

May 27, 2026May 28 11:24 PMRamy FaridDirector
Grant/Award
16,000$9.1016,000(D)

View →

May 27, 2026May 28 11:23 PMBISCHOFBERGER NORBERT WDirector
Grant/Award
16,000$9.1016,000(D)

View →

Feb 24, 2026Feb 26 9:56 PMVicki L SatoDirector
Option Exercise
42,377$1.490(D)

View →

Feb 22, 2026Feb 25 12:13 AMBrent SabatiniSVP, Chief Accounting Officer
Grant/Award
50,000$7.5650,000(D)

View →

Feb 22, 2026Feb 25 12:12 AMJason O'ByrneEVP & Chief Financial Officer
Grant/Award
110,000$7.56110,000(D)

View →

Feb 22, 2026Feb 25 12:11 AMMark EisnerEVP and Chief Medical Officer
Grant/Award
110,000$7.56110,000(D)

View →

Feb 22, 2026Feb 25 12:10 AMVerneuil Vanina deEVP, General Counsel, Corp Sec
Grant/Award
110,000$7.56110,000(D)

View →

Feb 22, 2026Feb 25 12:09 AMBacker Marianne DeDirector, Chief Executive Officer
Grant/Award
570,000$7.56570,000(D)

View →